Abstract

Pruritus is a very common chronic and frustrating symptom that considerably affects the quality of life of patients with end-stage renal disease. The current review examined the updates in the epidemiology, pathophysiology, and management of uraemic pruritus. Recently, there has been reduction in the prevalence of uraemic pruritus. With few exceptions, there have been no significant differences in the prevalence of uraemic pruritus by age, gender, and type of dialysis. However, pre-dialysis prevalence was lower than during dialysis prevalence. In recent years, new pathophysiologic hypotheses (immune and opioid) have been postulated and other hypotheses have been undermined (serotonin). There have been several anti-pruritic therapies examined among hemodialysis patients, including efficient dialysis, topical medications, systemic medications, physical and alternative treatments, and surgical treatments. However, none is considered the drug of choice or exclusively efficient in all patients. Several new medications have been examined in the last decade. However, for many of these medications, the evidence is still insufficient for their recommendations. After all advances in dialysis techniques and the availability of multiple therapies, uraemic pruritus is still a significant problem among hemodialysis patients that warrant further research.

Keywords: Pruritus · uremia · kidney failure · renal dialysis · drug therapy

References

  1. 1.Manenti L, Tansinda P, Vaglio A. Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs 2009; 69:251-63.
  2. 2.Kfoury LW, Jurdi MA. Uremic pruritus. Journal of nephrology 2012; 25:644-52.
  3. 3.Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. American journal of kidney diseases: the official journal of the National Kidney Foundation 2007;50:11-20.
  4. 4.Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is stillamajorproblemforpatientswithend-stagerenal disease. J Am Acad Dermatol 2003;49:842-6.
  5. 5.Dyachenko P, Shustak A, Rozenman D. Hemodialysisrelated pruritus and associated cutaneous manifestations. Int J Dermatol 2006;45:664-7.
  6. 6.Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21:3495-505.
  7. 7.Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus--new perspectives and insights from recent trials. Nephrol Dial Transplant 2002;17:1558-63.
  8. 8.Berger TG, Steinhoff M. Pruritus and renal failure. Semin Cutan Med Surg 2011;30:99-100.
  9. 9.Susel J, Batycka-Baran A, Reich A, Szepietowski JC. Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Derm Venereol 2014;94:276-81.
  10. 10.Makhlough A, Emadi N, Sedighi O, Khademloo M, Bicmohamadi AR. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients. Iran J Kidney Dis 2013;7:42-6.
  11. 11.Lopes GB, Nogueira FC, de Souza MR, Penalva MA, de Amorim JL, Pisoni RL, et al. Assessment of the psychological burden associated with pruritus in hemodialysispatientsusingthekidneydiseasequality of life short form. Qual Life Res 2012;21:603-12.
  12. 12.Welter Ede Q, Frainer RH, Maldotti A, Losekann A, Weber MB. Evaluating the association between alterations in mineral metabolism and pruritus in hemodialysis patients. An Bras Dermatol 2011; 86: 31-6.
  13. 13.Melo NC, Elias RM, Castro MC, Romao JE, Jr., Abensur H. Pruritus in hemodialysis patients: the problem remains. Hemodial Int 2009;13:38-42.
  14. 14.Resic H, Alendar F, Kukavica N, Masnic F, Cengic B. Uremic Pruritus in Haemodialysis Patients. BANTAO Journal 2007;5:19-22.
  15. 15.Narita I, Alchi B, Omori K, Sato F, Ajiro J, Saga D, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 2006;69:1626-32.
  16. 16.Mistik S, Utas S, Ferahbas A, Tokgoz B, Unsal G, Sahan H, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol 2006; 20: 672-8.
  17. 17.Szepietowski JC, Sikora M, Kusztal M, Salomon J, Magott M, Szepietowski T. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol 2002;29:621-7.
  18. 18.Jamal A, Subramanian PT. Pruritus among End-Stage Renal Failure Patients on Hemodialysis. Saudi J Kidney Dis Transpl 2000;11:181-5.
  19. 19.Attia EA, Hassan SI, Youssef NM. Cutaneous disorders in uremic patients on hemodialysis: an Egyptian casecontrolled study. Int J Dermatol 2010;49:1024-30.
  20. 20.KhannaD,SingalA,KalraOP.Comparisonofcutaneous manifestations in chronic kidney disease with or without dialysis. Postgraduate medical journal 2010; 86:641-7.
  21. 21.YongDS,KwokAO,WongDM,Suen MH,ChenWT,Tse DM. Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care. Palliative medicine 2009;23:111-9.
  22. 22.Layegh P, Mojahedi MJ, Malekshah PE, Pezeshkpour F, Vahedian M, Nazemian F, et al. Effect of oral granisetron in uremic pruritus. Indian J Dermatol Venereol Leprol 2007;73:231-4. Review Article Updates on Uraemic Pruritus, Alsaidan MS 11  MAJMAAH JOURNAL HEALTH SCIENCE, 2015-vol 3, Issue 1
  23. 23.Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C,KieferT,etal.Theroleofmicro-inflammationinthe pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006;21:749-55.
  24. 24.TzeremasT,KobrinSM,BernsJS,SheridanAM.Uremic pruritus. UpToDate 2014:Sep 2014.
  25. 25.Johansson O, Hilliges M, Stahle-Backdahl M. Intraepidermal neuron-specific enolase (NSE)- immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett 1989;99:281-6.
  26. 26.Shavit L, Grenader T, Lifschitz M, Slotki I. Use of pregabalin in the management of chronic uremic pruritus. J Pain Symptom Manage 2013;45:776-81.
  27. 27.Stockenhuber F, Kurz RW, Sertl K, Grimm G, Balcke P. Increasedplasmahistaminelevelsinuraemicpruritus. Clinical science 1990;79:477-82.
  28. 28.Vessal G, Sagheb MM, Shilian S, Jafari P, Samani SM. Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study. Nephrol Dial Transplant 2010;25:1541-7.
  29. 29.Szepietowski JC, Reich A, Schwartz RA. Uraemic xerosis. Nephrol Dial Transplant 2004;19:2709-12.
  30. 30.Okada K, Matsumoto K. Effect of skin care with an emollient containing a high water content on mild uremic pruritus. Ther Apher Dial 2004;8:419-22.
  31. 31.Szepietowski JC, Reich A, Szepietowski T. Emollients with endocannabinoids in the treatment of uremic pruritus: discussion of the therapeutic options. Ther Apher Dial 2005;9:277-9.
  32. 32.Chou FF, Ho JC, Huang SC, Sheen-Chen SM. A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 2000;190:65-70.
  33. 33.Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 1998;78:395-402.
  34. 34.Weisshaar E, Dunker N, Rohl FW, Gollnick H. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol 2004;13:298-304.
  35. 35.Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995;25:413-9.
  36. 36.Liakopoulos V, Krishnan M, Stefanidis I, Savaj S, Ghareeb S, Musso C, et al. Improvement in uremic symptoms after increasing daily dialysate volume in patients on chronic peritoneal dialysis with declining renal function. Int Urol Nephrol 2004;36:437-43.
  37. 37.Aoike I. Clinical significance of protein adsorbable membranes--long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 2007;22:v13-9.
  38. 38.Aucella F, Vigilante M, Gesuete A, Maruccio G, Specchio A, Gesualdo L. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role? Nephrol Dial Transplant 2007;22 Suppl 5:v8-12.
  39. 39.Kato A, Takita T, Furuhashi M, Takahashi T, Watanabe T,MaruyamaY,etal. Polymethylmethacrylateefficacy in reduction of renal itching in hemodialysis patients: crossover study and role of tumor necrosis factoralpha. Artificial organs 2001;25:441-7.
  40. 40.Lin HH, Liu YL, Liu JH, Chou CY, Yang YF, Kuo HL, et al. Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney. Artificial organs 2008;32:468-72.
  41. 41.Chen YC, Chiu WT, Wu MS. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus. Am J Kidney Dis 2006;48:69-76.
  42. 42.Young TA, Patel TS, Camacho F, Clark A, Freedman BI, Kaur M, et al. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatolog Treat 2009;20:76-81.
  43. 43.Makhlough A, Ala S, Haj-Heydari Z, Kashi Z, Bari A. Topical capsaicin therapy for uremic pruritus in patients on hemodialysis.Iran J Kidney Dis 2010;4: 137-40.
  44. 44.Weisshaar E, Dunker N, Gollnick H. Topical capsaicin therapyinhumanswithhemodialysis-relatedpruritus. Neurosci Lett 2003;345:192-4.
  45. 45.Pauli-Magnus C, Klumpp S, Alscher DM, Kuhlmann U, MettangT.Short-termefficacyoftacrolimusointment in severe uremic pruritus. Perit Dial Int 2000;20: 802-
  46. 46.Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 2004;19:1895-901.
  47. 47.Duque MI, Yosipovitch G, Fleischer AB, Jr., Willard J, Freedman BI. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol 2005;52:519-21.
  48. 48.Legroux-Crespel E, Cledes J, Misery L. A comparative study on the effects of naltrexone and loratadine on uremic pruritus. Dermatology 2004;208:326-30.
  49. 49.Marquez D, Ramonda C, Lauxmann JE, Romero CA, Vukelic VL, Martinatto C, et al. Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin. Jornal brasileiro de nefrologia: 'orgao oficial de Sociedades Brasileira e Latino- Americana de Nefrologia 2012;34:148-52.
  50. 50.Pour-Reza-Gholi F, Nasrollahi A, Firouzan A, Nasli EsfahaniE,FarrokhiF.Low-dosedoxepinfortreatment of pruritus in patients on hemodialysis. Iran J Kidney Review Article Updates on Uraemic Pruritus, Alsaidan MS 12  MAJMAAH JOURNAL HEALTH SCIENCE, 2015-vol 3, Issue 1 Dis 2007;1:34-7.
  51. 51.Rosner MH. Cromolyn sodium: a potential therapy for uremic pruritus? Hemodial Int 2006;10:189-92.
  52. 52.Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebocontrolled, double-blind trial. Nephrol Dial Transplant 2004;19:3137-9.
  53. 53.Manenti L, Vaglio A, Costantino E, Danisi D, Oliva B, Pini S, et al. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation. J Nephrol 2005;18:86-91.
  54. 54.Naini AE, Harandi AA, Khanbabapour S, Shahidi S, Seirafiyan S, Mohseni M. Gabapentin: a promising drug for the treatment of uremic pruritus. Saudi J Kidney Dis Transpl 2007;18:378-81.
  55. 55.RazeghiE,EskandariD,GanjiMR,MeysamieAP,Togha M, Khashayar P. Gabapentin and uremic pruritus in hemodialysis patients. Renal Fail 2009;31:85-90.
  56. 56.Solak Y, Biyik Z, Atalay H, Gaipov A, Guney F, Turk S, et al. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. Nephrology 2012;17:710-7.
  57. 57.Aperis G, Paliouras C, Zervos A, Arvanitis A, Alivanis P. The use of pregabalin in the treatment of uraemic pruritus in haemodialysis patients. J Ren Care 2010;36:180-5.
  58. 58.YueJ,JiaoS,XiaoY,RenW,ZhaoT,MengJ.Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. Int Urol Nephrol. 2015; 47:161-7
  59. 59.Rayner H, Baharani J, Smith S, Suresh V, Dasgupta I. Uraemic pruritus: relief of itching by gabapentin and pregabalin. Nephron Clin Pract 2012;122:75-9.
  60. 60.PeerG,KivityS,AgamiO,FiremanE,SilverbergD,Blum M, et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996;348:1552-4.
  61. 61.Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, doubleblind, placebo-controlled crossover study. J Am Soc Nephrol 2000;11:514-9.
  62. 62.Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, et al. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 2005;16:3742-7.
  63. 63.Kumagai H, Ebata T, Takamori K, Muramatsu T, NakamotoH,SuzukiH.Effectofanovelkappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 2010;25:1251-7.
  64. 64.Kumagai H, Ebata T, Takamori K, Miyasato K, Muramatsu T, Nakamoto H, et al. Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol 2012;36:175-83.
  65. 65.Inui S, Shirakawa Y, Itami S. Effect of nalfurafine hydrochloride on pruritus and anxiety level in hemodialysis patients. J Dermatol 2012;39:886-7.
  66. 66.Deshpande PV. Ondansetron for paediatric uraemic pruritus: a case report. Pediatr Nephrol 2004;19:694-
  67. 67.Ashmore SD, Jones CH, Newstead CG, Daly MJ, Chrystyn H. Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J kidney diseases 2000;35:827-31.
  68. 68.Murphy M, Reaich D, Pai P, Finn P, Carmichael AJ. A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch. Br J Dermatol 2003;148:314-7.
  69. 69.Albares MP, Betlloch I, Guijarro J, Vergara G, Pascual JC, Botella R. Severe pruritus in a haemodialysed patient: dramatic improvement with granisetron. The Br J Dermatol 2003;148:376-7.
  70. 70.Shakiba M, Sanadgol H, Azmoude HR, Mashhadi MA, Sharifi H. Effect of sertraline on uremic pruritus improvement in ESRD patients. Int J Nephrol 2012;2012:363901.
  71. 71.Chan KY, Li CW, Wong H, Yip T, Chan ML, Cheng HW, et al. Use of sertraline for antihistamine-refractory uremic pruritus in renal palliative care patients. J Palliat Med 2013;16:966-70.
  72. 72.Nasrollahi AR, Miladipour A, Ghanei E, Yavari P, Haghverdi F. Montelukast for treatment of refractory pruritus in patients on hemodialysis. Iran J Kidney Dis2007;1:73-7.
  73. 73.Begum R, Belury MA, Burgess JR, Peck LW. Supplementation with n-3 and n-6 polyunsaturated fattyacids:effectsonlipoxygenaseactivityandclinical symptoms of pruritus in hemodialysis patients.J Ren Nutr 2004;14:233-41.
  74. 74.Ghanei E, Zeinali J, Borghei M, Homayouni M. Efficacy of omega-3 fatty acids supplementation in treatment of uremic pruritus in hemodialysis patients: a doubleblind randomized controlled trial. Iran Red Crescent Med J 2012;14:515-22.
  75. 75.El-Shafey EM, Alsahow AE, Alsaran K, Sabry AA, Atia M. Cinacalcet hydrochloride therapy for secondary hyperparathyroidism in hemodialysis patients. Ther Apher Dial 2011;15:547-55.
  76. 76.Rivard J, Lim HW. Ultraviolet phototherapy for pruritus. Dermatologic therapy 2005;18:344-54.
  77. 77.SzepietowskiJC,MoritaA,TsujiT.UltravioletBinduces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Medical Review Article Updates on Uraemic Pruritus, Alsaidan MS 13  MAJMAAH JOURNAL HEALTH SCIENCE, 2015-vol 3, Issue 1 hypotheses 2002;58:167-70.
  78. 78.Ohe S, Danno K, Sasaki H, Isei T, Okamoto H, Horio T. Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol 2004;50:892-4.
  79. 79.Ada S, Seckin D, Budakoglu I, Ozdemir FN. Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study. J Am Acad Dermatol 2005;53:149-51.
  80. 80.Wang TJ, Lan LC, Lu CS, Lin KC, Tung HH, Wu SF, et al. Efficacy of narrowband ultraviolet phototherapy on renal pruritus. J Clin Nurs 2014;23:1593-602.
  81. 81.Ko MJ, Yang JY, Wu HY, Hu FC, Chen SI, Tsai PJ, et al. Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial. Br J Dermatol 2011;165:633-9.
  82. 82.Kim KH, Lee MS, Choi S-M, Ernst E. Acupuncture for Treating Uremic Pruritus in Patients with End-Stage Renal Disease: A Systematic Review. J Pain Symptom Manage 2010;40:117-25.
  83. 83.Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010;49:1-11.
  84. 84.Tajbakhsh R, Dehghan M, Azarhoosh R, Haghighi AN, Sadani S, Zadeh SS, et al. Mucocutaneous manifestations and nail changes in patients with endstage renal disease on hemodialysis. Saudi J Kidney Dis Transpl, Saudi Arabia 2013;24:36-40.
  85. 85.Deshmukh SP, Sharma YK, Dash K, Chaudhari NC, Deo KS.Clinicoepidemiologicalstudyofskinmanifestations in patients of chronic renal failure on hemodialysis. Indian Dermatol Online J 2013;4:18-21.
  86. 86.Falodun O, Ogunbiyi A, Salako B, George AK. Skin changes in patients with chronic renal failure. Saudi J Kidney Dis Transpl, Saudi Arabia 2011;22:268-72.
  87. 87.Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Srinivas CR, Mathew AC. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol 2006;72:119-25.
  88. 88.DuqueMI,ThevarajahS,ChanYH,TuttleAB,Freedman BI, Yosipovitch G. Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clinical nephrology 2006;66:184-91.
  89. 89.Subach RA, Marx MA. Evaluation of uremic pruritus at an outpatient hemodialysis unit. Renal Fail 2002;24:609-14.
  90. 90.Silverberg NB, Singh A, Laude TA. Cutaneous manifestations of chronic renal failure in children of color. Pediatr Dermatol 2001;18:199-204. Review Article Updates on Uraemic Pruritus, Alsaidan MS
Majmaah Journal of Health Sciences · eISSN 1658-8223 · Majmaah University · open access